Aurobindo Pharma Ltd (AUROPHARMA) Financial Statements

4 Followers

Aurobindo Pharma Ltd Financial Overview

Aurobindo Pharma Ltd's market cap is currently ₹881.60B. The company's EPS TTM is ₹58.93; its P/E ratio is 18.87; and it has a dividend yield of 0.33%. Aurobindo Pharma Ltd is scheduled to report earnings on May 21, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Income Statement
Total Revenue	₹ 317.24B	₹ 290.02B	₹ 248.55B	₹ 234.55B	₹ 247.75B
Gross Profit	₹ 182.40B	₹ 160.16B	₹ 132.14B	₹ 130.06B	₹ 145.85B
Operating Income	₹ 120.01B	₹ 104.50B	₹ 81.05B	₹ 78.06B	₹ 94.03B
EBITDA	₹ 64.36B	₹ 57.64B	₹ 36.34B	₹ 43.11B	₹ 53.95B
Net Income	₹ 34.86B	₹ 31.73B	₹ 19.27B	₹ 26.48B	₹ 53.35B
Balance Sheet
Cash & Short-Term Investments	₹ 82.36B	₹ 63.25B	₹ 62.24B	₹ 45.58B	₹ 56.21B
Total Assets	₹ 497.85B	₹ 450.72B	₹ 398.90B	₹ 339.22B	₹ 338.54B
Total Debt	₹ 82.63B	₹ 66.48B	₹ 52.86B	₹ 32.79B	₹ 53.39B
Net Debt	₹ 273.80M	₹ 32.54B	₹ 8.90B	₹ -8.84B	₹ -343.90M
Total Liabilities	₹ 171.38B	₹ 152.21B	₹ 130.38B	₹ 93.48B	₹ 119.25B
Stockholders' Equity	₹ 326.53B	₹ 298.43B	₹ 268.40B	₹ 245.76B	₹ 219.30B
Cash Flow
Free Cash Flow	₹ 19.57B	₹ -11.27B	₹ -3.34B	₹ 23.12B	₹ 14.55B
Operating Cash Flow	₹ 39.25B	₹ 24.35B	₹ 23.87B	₹ 50.16B	₹ 33.29B
Investing Cash Flow	₹ -18.76B	₹ -42.56B	₹ -39.78B	₹ -32.12B	₹ 5.99B
Financing Cash Flow	₹ 1.20B	₹ 8.00B	₹ 18.14B	₹ -29.69B	₹ -13.65B

Currency in INR

Aurobindo Pharma Ltd Earnings and Revenue History

Income Statement >

Aurobindo Pharma Ltd Debt to Assets

Balance Sheet >

Aurobindo Pharma Ltd Cash Flow

Cash Flow >

Aurobindo Pharma Ltd Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >